Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Review of Meta-Analyses

[1] Cook DJ(1995)Methodologic guidelines for systematic reviews of randomized control trials in health care from the Potsdam Consultation on Meta-Analysis J Clin Epidemiol 48 167-171

[2] Sackett DL(2001)Meta-analyses of randomised clinical trials in oncology Lancet Oncol 2 475-482

[3] Spitzer WO(1997)A guide to interpreting discordant systematic reviews Can Med Assoc J 156 1411-1416

[4] Pignon JP(1997)Discrepancies between meta-analyses and subsequent large randomized, controlled trials N Engl J Med 337 536-542

[5] Hill C(2006)Neoadjuvant concurrent chemoradiation with weekly paclitaxel and carboplatin for patients with oesophageal cancer: a phase II study Br J Cancer 94 1389-1394

[6] Jadad AR(2007)Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis Lancet Oncol 8 226-234

[7] Cook DJ(2004)Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis Gut 53 925-930

[8] Browman GP(2003)Neoadjuvant treatment for resectable cancer of the esophagus and the gastroesophageal junction: a meta-analysis of randomized clinical trials Ann Surg Oncol 10 754-761

[9] LeLorier J(2003)A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer Am J Surg 185 538-543

[10] Gregoire G(1991)Publication bias in clinical research Lancet 337 867-872

[1] Cook DJ(1995)Methodologic guidelines for systematic reviews of randomized control trials in health care from the Potsdam Consultation on Meta-Analysis J Clin Epidemiol 48 167-171

[2] Sackett DL(2001)Meta-analyses of randomised clinical trials in oncology Lancet Oncol 2 475-482

[3] Spitzer WO(1997)A guide to interpreting discordant systematic reviews Can Med Assoc J 156 1411-1416

[4] Pignon JP(1997)Discrepancies between meta-analyses and subsequent large randomized, controlled trials N Engl J Med 337 536-542

[5] Hill C(2006)Neoadjuvant concurrent chemoradiation with weekly paclitaxel and carboplatin for patients with oesophageal cancer: a phase II study Br J Cancer 94 1389-1394

[6] Jadad AR(2007)Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis Lancet Oncol 8 226-234

[7] Cook DJ(2004)Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis Gut 53 925-930

[8] Browman GP(2003)Neoadjuvant treatment for resectable cancer of the esophagus and the gastroesophageal junction: a meta-analysis of randomized clinical trials Ann Surg Oncol 10 754-761

[9] LeLorier J(2003)A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer Am J Surg 185 538-543

[10] Gregoire G(1991)Publication bias in clinical research Lancet 337 867-872